Table 1 Demographic and Clinical Characteristics of the Study Population
Study cohort | Conservative | Treatment | |||
|---|---|---|---|---|---|
Characteristics | (n = 29) | (n = 15) | (n = 12) | P value | |
Sex(female) | 11/29(38%) | 7/15(47%) | 3/12(33%) | 0.42 | |
Prenatal diagnosis gestation (wk) | 34 ± 4.3 | 33.6 ± 4 | 34.8 ± 4.8 | 0.56 | |
Birth gestation (wk) | 38.6 ± 1.4 | 37 ~ 41 | 37 ~ 40 | 0.28 | |
Birth weight (g) | 3,181 ± 310 | 3,200 ± 355 | 3,185 ± 262 | 1.00 | |
visiting ages(d) | 17 ± 13 | 1–30 | 1–30 | 0.87 | |
Delivery pattern | 0.71 | ||||
Normal labor | 19(66%) | 10(67%) | 7(58%) | ||
Cesarean section | 10(34%) | 5(33%) | 5(42%) | ||
Postnatal Initial ultrasound | 0.10 | ||||
Tumor size (cm) | 6.5 ± 1.7 | 6.0 ± 1.1 | 7.2 ± 2.1 | ||
Location | 0.81 | ||||
Right lobe | 22(76%) | 12(80%) | 8(67%) | ||
Left lobe | 4(14%) | 2(13%) | 2(17%) | ||
Right and left lobes | 3(10%) | 1(7%) | 2(17%) | ||
Cardiothoracic ratio(>0.6) | 11/21(52%) | 3/8(38%) | 8/11(73%) | 0.02 | |
Clinical features | |||||
Cutaneous hemangioma | 2/29(7%) | 0/15 | 2/12(17%) | 0.19 | |
Abdominal syndrome | compartment | 3/29(10%) | 0/15 | 3/12(25%) | 0.08 |
Hepatic arteriovenous fistula (AVF) | 4/29(14%) | 0/15 | 4/12(33%) | 0.03 | |
Congestive heart failure | 5/29(17%) | 0/15 | 5/12(42%) | 0.01 | |
Pulmonary hypertension | 8/29(28%) | 1/15(7%) | 7/12(58%) | 0.01 | |
Thrombocytopenia | 6/29(21%) | 1/15(7%) | 4/12(33%) | 0.14 | |
Elevated TSH | 4/18(22%) | 1/7(14%) | 3/11(27%) | 1.00 | |
Anemia | 4/29(14%) | 1/15(7%) | 3/12(25%) | 0.29 | |
Coagulation abnormalities | 19/26(73%) | 10/14(71%) | 9/12(75%) | 1.00 | |
Elevated liver enzymes | 19/23(83%) | 11/12(92%) | 7/9(78%) | 0.55 | |
Albumin(g/l) | 34.0 ± 4.1(n = 23) | 34 ~ 40(n = 12) | 25 ~ 40(n = 9) | 0.02 | |
AFP(ng/ml) | 48,209 ± 36,537 (n = 21) | 52,036 ± 31,672 (n = 12) | 52,275 ± 42,924 (n = 7) | 0.99 | |